These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7980625)

  • 41. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
    Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D
    Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitro reduction as an electronic switch for bioreductive drug activation.
    Siim BG; Denny WA; Wilson WR
    Oncol Res; 1997; 9(6-7):357-69. PubMed ID: 9406242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards.
    Wilson WR; Hicks KO; Pullen SM; Ferry DM; Helsby NA; Patterson AV
    Radiat Res; 2007 Jun; 167(6):625-36. PubMed ID: 17523848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NLNQ-1, a 2-[3-(2-nitro-1-imidazolyl) propylamino]-3-chloro-1,4-naphthoquinone, as a hypoxia-selective cytotoxin and radiosensitizer.
    Papadopoulou MV; Bloomer WD
    In Vivo; 2008; 22(3):285-8. PubMed ID: 18610737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions of the carcinogen 4-nitroquinoline 1-oxide with the non-protein thiols of mammalian cells.
    Varnes ME; Biaglow JE
    Cancer Res; 1979 Aug; 39(8):2960-5. PubMed ID: 110443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sulfoxide-containing aromatic nitrogen mustards as hypoxia-directed bioreductive cytotoxins.
    Sun ZY; Botros E; Su AD; Kim Y; Wang E; Baturay NZ; Kwon CH
    J Med Chem; 2000 Nov; 43(22):4160-8. PubMed ID: 11063612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive compound as a hypoxia-selective cytotoxin.
    Papadopoulou MV; Ji M; Rao MK; Bloomer WD
    Oncol Res; 2000; 12(4):185-92. PubMed ID: 11341468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indolequinone bioreductive drugs: kinetic factors which influence selectivity for hypoxia.
    Everett SA; Naylor MA; Nolan J; Patel KB; Wardman P
    Anticancer Drug Des; 1998 Sep; 13(6):635-53. PubMed ID: 9755722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoxia-dependent retinal toxicity of bioreductive anticancer prodrugs in mice.
    Lee AE; Wilson WR
    Toxicol Appl Pharmacol; 2000 Feb; 163(1):50-9. PubMed ID: 10662604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis".
    Denny WA; Atwell GJ; Anderson RF; Wilson WR
    J Med Chem; 1990 May; 33(5):1288-95. PubMed ID: 2329552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the nitro functionality in the DNA binding of 3-nitro-10-methylbenzothiazolo[3,2-a]quinolinium chloride.
    Colón IG; González FA; Cordero M; Zayas B; Velez C; Cox O; Kumar A; Alegría AE
    Chem Res Toxicol; 2008 Sep; 21(9):1706-15. PubMed ID: 18759504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failla Memorial Lecture. Redox, radiation, and reductive bioactivation.
    Adams GE
    Radiat Res; 1992 Nov; 132(2):129-39. PubMed ID: 1438693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reductive metabolism and hypoxia-selective toxicity of nitracrine.
    Wilson WR; Denny WA; Stewart GM; Fenn A; Probert JC
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1235-8. PubMed ID: 3744944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nitrobenzyl halides and carbamates as prototype bioreductive alkylating agents.
    Teicher BA; Sartorelli AC
    J Med Chem; 1980 Aug; 23(8):955-60. PubMed ID: 7190617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizers.
    Naylor MA; Stephens MA; Stratford IJ; Keohane A; O'Neill P; Threadgill MD; Webb P; Fielden EM; Adams GE
    Anticancer Drug Des; 1991 Jul; 6(3):151-67. PubMed ID: 1872946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
    Plumb JA; Gerritsen M; Workman P
    Br J Cancer; 1994 Dec; 70(6):1136-43. PubMed ID: 7526885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and evaluation of nitroheterocyclic phosphoramidates as hypoxia-selective alkylating agents.
    Borch RF; Liu J; Schmidt JP; Marakovits JT; Joswig C; Gipp JJ; Mulcahy RT
    J Med Chem; 2000 Jun; 43(11):2258-65. PubMed ID: 10841804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells.
    Seow HA; Penketh PG; Shyam K; Rockwell S; Sartorelli AC
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9282-7. PubMed ID: 15964988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of 4-nitroquinoline 1-oxide to 4-hydroxyaminoquinoline 1-oxide in lysates of cytomegalovirus-infected cells.
    Speelman DJ; Lund H; Culling A; Kittredge JS; Williams BJ; Albrecht T
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2511-5. PubMed ID: 6315869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.